ANXA1 via its receptor FPR2 has been shown to mitigate cerebrovascular injury by limiting immune cell infiltration and pro-inflammatory thrombotic cytokine production in mouse models of ischemic stroke [96–98]. The gene discussed is FPR2; the disease is ischemic stroke.